Lobar pneumonia is a common clinical lung manifestation of acute Q fever that contrasts with the few cases of interstitial pneumonia reported in association with persistent focalized Coxiella burnetii infection [1, 2] . Interstitial lung disease (ILD) is a heterogeneous group of parenchymal disorders that are identified at chest computed tomography (CT) [3] . The disease is conventionally classified into 4 categories: ILD of known causes, idiopathic interstitial pneumonia, granulomatous disease, and other ILDs [4] .
The role of infectious disease in ILDs and, notably, in idiopathic pulmonary fibrosis (IPF), is a major concern for clinicians. The influence of the lung microbiome in the development and progression of IPF has been raised in recent years [5] . Although fungi and viruses have been described as being responsible for ILD, some cases of ILD/IPF remain unrelated to any causative factor, pointing toward the need to expand the diagnostic investigation to atypical infectious agents.
In this article, we report a case of IPF associated with C. burnetii infection as documented in situ. We thus investigate C. burnetii infection as a cofactor for ILD and describe a series of cases with clinical, radiological, and immunological patterns.
MATERIAL AND METHODS

Data Collection
The French National Reference Center (NRC) for Q fever receives specimens from patients with suspected Q fever from all over France and abroad. For each positive C. burnetii serologic result, clinical data are collected by phone and entered into a computerized database. In this study, patients who had reported ILD were asked to provide corresponding complementary data by questionnaire to clarify the patient's personal and familial medical history, profession, tobacco use, bird or hay contact, medication, drug use, pulmonary function test results, CT scan data, and outcome. In addition, thoracic CT scans were requested for centralized review.
Q Fever Diagnosis and Definition
Serology was performed with indirect immunofluorescence, as described elsewhere [1] . Real-time polymerase chain reaction (PCR) targeting the IS1111 gene, culture, immunohistochemistry, immunofluorescence, and fluorescence in situ hybridization (FISH) were performed as described elsewhere [1, 6] .
Primary C. burnetii infection was defined by the association of clinical symptoms (fever, pneumonia, or transaminitis) with the serologic criteria for phase II immunoglobulin G levels ≥200 and phase II immunoglobulin M levels ≥50, seroconversion, or a positive PCR result [1] . Persistent focalized C. burnetii infections, such as endocarditis, vascular infection, osteoarticular infection, and lymphadenitis, were defined according to the criteria updated in 2017 [1] .
Diagnosis of ILD
In accordance with the American Thoracic Society and the European Respiratory Society international multidisciplinary classification update, the diagnosis of ILD was made by a multidisciplinary team, including a radiologist, a histopathologist, and a physician [3, 7] . High-resolution CT images were checked for irregular reticular opacities, traction bronchiectasis, honeycombing cysts, and ground-glass opacification, and their anatomic distributions were specified. Finally, high-resolution CT images were classified according to standards of interpretation as definite usual interstitial pneumonia, nonspecific interstitial pneumonia, or unclassifiable ILD patterns [3, 7] . Where a lung biopsy specimen was available, a centralized histological reading was performed.
Biological assessment of ILD causes related to immune and infectious disorders were explored with antineutrophil cytoplasmic antibodies, antinuclear antibodies, rheumatoid factor, antisynthetase antibodies, angiotensin-converting enzyme, and serology for human immunodeficiency virus, rickettsiosis, chlamydia, and mycoplasma. Blood eosinophilia was checked, as well as cardiac and renal function.
RESULTS
ILD Among Patients With Q Fever
Between January 1991 and December 2016, we screened the 2580 patients with positive C. burnetii serologic results attending the NRC. Of them, 516 were recorded as having pneumonia and 28 as having ILD. The questionnaire was completed for 16 patients, and thoracic CT scan images were centrally reviewed for 12. ILD was confirmed in 7 patients (Supplementary Figure 1) .
Index Case Patient
A 73-year-old man with a 10-day history of febrile cough and dyspnea was admitted to the intensive care unit (ICU) for respiratory failure. His medical history included diabetes mellitus, arterial hypertension, past tobacco addiction, and unclassified ILD diagnosed 6 years previously. His daily treatment included metformin, atorvastatin, diltiazem, and tiotropium bromide inhalation. Lung biopsy specimens confirmed the diagnosis of interstitial fibrosis ( Figure 1A ). The C. burnetii serologic result was positive ( Table 1) . Results of anti-C. burnetii immunohistochemistry ( Figure 1B) and FISH targeting C. burnetii ( Figure 1C ) were positive at lung biopsy. Noninvasive ventilation, broadspectrum antibiotics (imipenem, amikacin, and linezolid), and doxycycline in association with hydroxychloroquine led to a A B D E C partial clinical improvement. Corticosteroids and rituximab were introduced at discharge, and doxycycline was maintained for the duration of immunosuppression. The patient returned home after a 2-week hospitalization, and no worsening was observed up to 1 year later.
Case Summaries in 6 Additional Cases
Of the 7 patients analyzed with C. burnetii ILD, the mean age at Q fever diagnosis was 67.5 years (standard deviation, 11 years). Three patients had been previously treated with immunosuppressive drugs for autoimmune disease (Table 1 ). All patients were admitted to the hospital for dyspnea, and 3 had an associated fever. Four patients were hospitalized in the ICU. All patients had C. burnetii antibody titers consistent with a persistent infection ( Table 1 ). All 7 patients presented with advanced lesions of interstitial lung fibrosis ( Figure 1D and 1E) . Five patients had a medical history with a possible underlying factor that could have encouraged ILD, including amiodarone use (n = 2), asbestos exposure (n = 1), and autoimmune disease (n = 4) ( Table 1) . Results of microbiological tests for differential diagnoses were negative for all patients. Lung function test data were available for 5 patients, and all showed a severe restrictive syndrome. One patient died; he was receiving immunosuppressive treatment for polyarthritis and macrolides as the only antibiotic strategy. The other patients showed improvement, with a decrease in C. burnetii antibodies with serologic control (n = 5).
Patients were discharged to receive home care and follow-up of the respiratory disease. None of the conditions showed worsening up to 1 year later.
DISCUSSION
We described 7 patients with C. burnetii persistent infection and confirmed ILD from the 2580 patients with Q fever attending the French NRC. ILD appeared as a possible presentation of persistent C. burnetii infection. For the first time, to our knowledge, we documented the presence of C. burnetii in situ, in the fibrotic lung tissue. All 7 patients presented with persistent C. burnetii infection. Although it is notable that 5 of the 7 patients had concomitant factors favoring ILD, the role of C. burnetii in the development or intensification of ILD cannot be ruled out. A codiagnosis of lung fibrosis and C. burnetii infection was first described in 1947 after an institutional pneumonia outbreak that involved employees of the National Institutes of Health in Bethesda, Maryland, near Washington, DC [8, 9] . Of 15 patients from the above-mentioned study with a Q fever diagnosis, 1 man died; he was 59 years old, and his autopsy revealed interstitial lung lesion with fibrosis [9] . Lung fibrosis was likewise reported in 1979 after a Russian Q fever outbreak, in which hilar and severe lung fibrosis were described months or years after C. burnetii infection [10] . Since then, only 1 case of progressive restrictive lung disease has been described in the literature in association with persistent C. burnetii infection [12] . In our series, it is notable that 2 patients resided in French Guiana, where Q fever is endemic.
In our patient series, the coexistence of persistent C. burnetii infection and ILD appears as a serious disease. One patient died of acute respiratory failure. More than half of the patients (n = 4) were hospitalized in the ICU. All patients had advanced fibrotic lesions on CT scans.
C. burnetii infection was associated with autoimmune disease in 4 patients, and all of them presented with an additional infectious focus (endocarditis in 3 and granulomatous hepatitis in 1). Whereas autoimmune diseases could be responsible for inappropriate secretion of antibodies, the identification of a persistent C. burnetii infectious focus suggests rather that immunosuppression promotes persistent infection or that Q fever triggers immune disorders [9] . The association of C. burnetii with antiphospholipid antibody syndrome and valvular vegetation and with B-cell non-Hodgkin lymphoma are striking examples of this last hypothesis [1, 6] . In the literature, 4 patients with acute Q fever and positive results for antineutrophil cytoplasmic antibodies have been described (Supplementary Table 1) , and 11 cases in association with rheumatoid arthritis [11, 12] .
ILD was the unique focus of Q fever infection identified for 3 patients. A new definition score for C. burnetii-associated ILD could be proposed based on microbiological, histological, and radiographic aspects (Supplementary Table 2 ). C. burnetiiassociated ILD is considered "definite" when the bacterium is identified in the fibrotic lung biopsy by means of PCR, culture, immunohistochemistry, or FISH. C. burnetii-associated ILD is categorized as "possible" when a patient presents with a C. burnetii-positive serologic result consistent with C. burnetii infection and ILD at thoracic CT imaging. Doxycycline in association with hydroxychloroquine is the reference treatment for C. burnetii ILD [1] .
We reported 7 cases of C. burnetii associated with ILD, 1 definite and 6 possible cases. All presented with severe fibrotic lung lesions. Given the dramatic consequences of ILD and lung fibrosis, C. burnetii serology should be performed in the initial investigations of patients with ILD, even when another cofactor or cause is suspected, and especially in endemic areas. Further investigations are necessary to identify a causal link between these 2 diseases.
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